Growth & Sustainability

SUSTAINABILITY IS DEEP-ROOTED IN ALL OUR DECISION MAKING

We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.

RECENT UPDATES

15 OCTOBER 2021

COVID-19 VACCINE FOR CHILDREN 3 TO 11 YEARS WILL ACCELERATE HERD IMMUNITY FOR THE WHOLE POPULATION

13 OCTOBER 2021

COVID-19 BOOSTER SHOT SHOWS IMMENSE INCREASE IN NEUTRALISING ANTIBODIES UP TO 20 TIMES AFTER SECOND DOSE, SAME VACCINE RECOMMENDED

4 OCTOBER 2021

SINOVAC COVID-19 VACCINE SAFE FOR CHILDREN AND ADOLESCENTS, AVAILABLE FOR PRIVATE MARKET

12 SEPTEMBER 2021

ANALYSIS ON COVID-19 VACCINATION RAW DATA MUST USE SCIENTIFIC METHODS AND PEER-REVIEWED TO AVOID MISINTERPRETATION AND CONFUSION

12 SEPTEMBER 2021

VACCINE REMINDER CARD IS VALID WHILE MYSEJAHTERA SOLVES UPDATING ISSUES OF DIGITAL COVID-19 VACCINE CERTIFICATE

26 AUGUST 2021

PHARMANIAGA CONTINUES TO EXPLORE OVERSEAS EXPANSION OPPORTUNITIES FOR SINOVAC COVID-19 VACCINE SUPPLY

20 AUGUST 2021

HIGHER DEMAND ACROSS ALL BUSINESS SEGMENTS CONTRIBUTED TO PHARMANIAGA’S COMMENDABLE PERFORMANCE FOR Q2 2021

13 AUGUST 2021

PHARMANIAGA ACKNOWLEDGES BIG PHARMACY’S RETRACTION NOTICE

12 AUGUST 2021

PHARMANIAGA CONTINUES TO SUPPLY ADDITIONAL 6 MILLION DOSES OF SINOVAC COVID-19 VACCINE TO MINISTRY OF HEALTH

3 AUGUST 2021

PHARMANIAGA ACKNOWLEDGES PATRICK TEOH’S PUBLIC APOLOGY